Phase 3 trial in 792 patients with locally advanced head and neck SCC: 55 Gy in 20 fractions over 4 weeks was non-inferior to accelerated 66 Gy in 33 fractions for both loco-regional control and grade 3+ late adverse events; 3-year differences were ≤1.4 points.
RCTn = 792
Bentzen et al. Hypofractionated Versus Normofractionated Accelerated Radiation Therapy With or Without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO): A Randomized, Open-Label, Phase 3, Noninferiority Trial